Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
169.6 USD | +2.87% | +0.50% | -6.03% |
May. 14 | BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024 | CI |
May. 09 | Beigene Q1 Loss Shrinks as Revenue Grows; Company's Shares Nearly 7% Up | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
17.24B | - | |||||
113B | ||||||
106B | ||||||
22.27B | - | |||||
22.22B | - | |||||
19.43B |
- Stock Market
- Equities
- BGNE Stock
- Charts BeiGene, Ltd.
- Sector Chart